Jubilant Life Sciences posts net loss of Rs 100.65 crore in Q4 Garima19 May 2019 9:30 AM ISTJubilant Life Sciences said its bottom line in the quarter was hit by a one-time loan settlement with IFC, that resulted in an exceptional item of Rs...
Glenmark expects generics to drive growth over next 3 yrs Ruby Khatun Khatun25 Sept 2017 10:37 AM ISTMumbai: Pharma firm Glenmark Pharmaceuticals has said its pipeline of specialty and innovative products over the next three to four years is expected...
Biocon aspiring for 1 billion dollar revenues by FY19 Ruby Khatun Khatun11 Sept 2017 10:22 AM ISTNew Delhi: Biocon is betting big on small molecules and generic formulations, biosimilars, branded formulations and research services as it targets $1...
